Reagent tube

Abstract
A reagent tube configured with a stellated shaped pattern, on its bottom interior surface, configured to facilitate complete or near-complete withdrawal of fluid from the tube, via a pipette tip. The reagent tube may be used for transporting reagents and for carrying out processing operations on biological samples with the reagents, such as preparing polynucleotides extracted from the sample for amplification.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The technology described herein generally relates to reagent tubes designed to facilitate pipetting of small volumes of liquid from within, and more particularly to reagent tubes that are used in extracting microfluidic quantities of polynucleotides in solution following extraction from biological samples.


2. Description of the Related Art


The medical diagnostics industry is a critical element of today's healthcare infrastructure. At present, however, diagnostic analyses no matter how routine have become a bottleneck in patient care. There are several reasons for this. For example, many diagnostic analyses can only be done with highly specialist equipment that is both expensive and only operable by trained clinicians. Such equipment is found in only a few locations, and often there is just one in any given urban area. This means that most hospitals are required to send out samples for analyses to these locations, thereby incurring shipping costs and transportation delays, and possibly even sample loss or mishandling.


Understanding that sample flow breaks down into several key steps, it would be desirable to consider ways to automate or make efficient as many of these as possible. In one key step, a biological sample, once extracted from a patient, must be put in a form suitable for a processing and detection regime that typically involves using PCR to amplify a vector of interest. Once amplified, the presence or absence of the vector in the sample needs to be determined unambiguously. Preparing samples for PCR is currently a time-consuming and labor intensive step, though not one requiring specialist skills, and could usefully be automated. By contrast, steps such as PCR and nucleotide detection have customarily only been within the compass of specially trained individuals having access to specialist equipment.


Sample preparation is labor intensive in part because of the number of reagents required, and the need for multiple liquid transfer (e.g., pipetting) operations. Furthermore, a trend towards portable diagnostic instruments, or those that can be easily installed in almost any healthcare setting (without requiring a dedicated facility), has meant that the instruments are configured to analyze very small (microfluidic or smaller) volumes of polynucleotide-containing solutions. With such volumes, it becomes important to minimize sample loss—such as from liquid transfer operations—during sample preparation. Even a loss of a very small fraction of a processing volume could result in loss of a significant number of copies of target polynucleotide and thereby result in a concomitant loss of amplification and detection sensitivity and—potentially—a false negative diagnosis. A major source of loss of liquid samples and solutions is from incomplete pipetting, where a pipette attempts to suck an entire quantity of fluid from a container, but where some fraction of that quantity is retained in the container, such as on the interior surfaces.


Various interior surface features in reagent tubes have been described elsewhere. U.S. Pat. No. 4,466,740 describes an array of reaction vessels on a plate, wherein each vessel has a conical interior lower surface that is stepped so that a number of concentric ridges of increasing diameter span between the bottom of the vessel and the vessel at its maximum width. Such a shape of interior surface is likely to present an increased surface area on which solution may remain during pipetting, and are unlikely to effectively channel the solution towards the location of a pipette tip. U.S. Pat. No. 6,143,250 (the '250 patent) describes liquid storage vessels having “ditches” in their lower interior surfaces that follow the interior surface of an inclined edge of the vessel. Although the '250 patent suggests that these grooves can be present in numbers of greater than two, and arranged radially with respect to the center of the vessel, such a configuration has at least the drawback that it would require a complex manufacture of the vessel, and are therefore limited to particular vessels, not necessarily those that are used in routine laboratory processes, such as biological sample preparation.


There is therefore a need for a method and apparatus of carrying out sample preparation on samples, so that loss of liquid volumes during liquid transfer is reduced. Such methods and apparatus could also find application to liquid transfer operations used in other fields, where mitigation of sample loss during work-up is important.


The discussion of the background herein is included to explain the context of the inventions described herein. This is not to be taken as an admission that any of the material referred to was published, known, or part of the common general knowledge as at the priority date of any of the claims.


Throughout the description and claims of the specification the word “comprise” and variations thereof, such as “comprising” and “comprises”, is not intended to exclude other additives, components, integers or steps.


SUMMARY OF THE INVENTION

The technology described herein includes a reagent tube comprising a pattern of ridges extending radially and centered at the bottom of the interior surface of the tube. Also contemplated are radially oriented patterns of grooves on the bottom interior surface of the tube.


The reagent tube described herein typically comprises a wall having an upper portion, usually cylindrical, and a lower portion, usually conical or tapering towards a bottom, and has an exterior surface and an interior surface. The pattern of ridges is typically star-shaped and is disposed on the interior surface of the tube, at the bottom of the tube.


The technology described herein further includes methods of using a reagent tube, as described herein, such as a method of removing all, or substantially all, of a liquid from the tube by use of a pipette tip. The pipette tip may be removably attached to a manually, such as hand-operated, pipette, or may be removably attached to an automatic dispensing apparatus.


The reagent tube herein typically finds use in sample preparation, that sequence of processing steps by which polynucleotide molecules, such as DNA and/or RNA, present in a biological sample (such as blood, sputum, semen, or urine), are extracted from their cellular matrix, and placed in a form suitable for amplification, such as by PCR, and subsequent detection as part of a diagnostic test.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A and 1B show a stellated feature on the interior of a reagent tube, in cross-sectional (FIG. 1A) and top plan (FIG. 1B) views.



FIGS. 2A, 2B, and 2C show a stellated feature on the interior of a reagent tube, in cross-sectional plan (FIG. 2A), top plan (FIG. 2B), and close-up (FIG. 2C) views.



FIG. 3 shows a sequence of pipetting operations in conjunction with a reagent tube having a stellated feature.



FIGS. 4A, 4B, 4C, and 4D show an embodiment of a reagent tube having a stellated feature as further described herein, in cross-sectional (FIG. 4A), top plan (FIG. 4B), side plan (FIG. 4C), and close-up (FIG. 4D) views.





DETAILED DESCRIPTION OF THE INVENTION

Reagent Tubes


The reagent tubes described herein are designed to facilitate pipetting of small volumes of liquid from within, such as to transfer the liquid to another container, with very little attendant loss of liquid.


The reagent tubes can be used in extracting microfluidic quantities of polynucleotides in solution following isolation of such polynucleotides from biological samples, such as in conjunction with a holder of various reagents as described in U.S. Patent Publication. No. 2009-0129978 A1, filed by ExpressMail on Jul. 14, 2008 (and entitled “Reagent Holder, and Kits Containing Same”, in the name of Wilson, et al.), and an automated pipette head and dispenser as described in U.S. Patent Publication No. 2009-0130745 A1, filed by ExpressMail on Jul. 14, 2008 (and entitled “Integrated Apparatus for Performing Nucleic Acid Extraction and Diagnostic Testing on Multiple Biological Samples”, in the name of Williams, et al.), both of which are incorporated herein by reference. Exemplary procedures for sample preparation from polynucleotide-containing biological samples are found in U.S. Patent Publication Nos. 2010-0009351 A1, and 2009-0131650 A1, both filed Jul. 11, 2008, and incorporated herein by reference.


However, reagent tubes consistent with the embodiments described herein are not exclusively for use with automated pipetting apparatus but also can be used in conjunction with manual processing, such as pipetting by hand.


Tubes consistent with the embodiments herein may have a variety of volumes, typically in the range 0.1 ml to 0.65 ml, such as 03 ml, 0.6 ml, or in the range 1.5-2.0 ml, or may have intermediate, or greater, volumes than those specifically delimited. They may also have a variety of shapes such as conical, barrel-shaped (wider at a middle portion than at top and bottom portions), or cylindrical with a tapered or conical bottom. Usually, reagent tubes are circular in cross-section, but other cross sections are possible and consistent herewith, and include but are not limited to: rectilinear, such as square or rectangular, like a cuvette; polygonal, such as pentagonal or hexagonal; and oval. Ordinarily, the tubes have a unitary construction, though in certain instances may be constructed from two or more parts fused or otherwise joined together as applicable. Typically, the tubes are configured to accept a pipette tip for deposit and/or retrieval of fluids.


The features of the reagent tubes as described herein may be found in or on the interior surfaces of many fluid containing vessels, including, but not limited to: vessels configured to carry out reactions, such as PCR tubes; arrays, such as microarray plates, having many vessels arranged in a single substrate; snap-in tubes, such as tubes that contain reagents and are shipped separately or loosely, but when used are snapped into a supporting member such as a rack or a holder, disposable tubes; re-usable tubes; tubes that are sealed to limit contact of their contents with air and/or moisture during storage or transport; tubes that are sealable and re-sealable, such as having a removable, or flip-up cap; tubes that can be labeled for a single use, or labeled for multiple uses; tubes that are made of a clear, or a translucent, or an opaque material, depending upon, e.g., photosensitivity of the contents; tubes that contain liquid reagents such as those that are directly pipetted out of the tubes; and tubes that contain solid, e.g., particulate, or lyophilized, reagents that are constituted into liquid form prior to pipetting, such as by dissolving upon contact with a liquid such as an aqueous buffer solution; and tubes that are made of plastic, or glass, or quartz.


As described elsewhere herein, the reagent tubes are configured to have a star-shaped—also referred to as stellated—pattern (see FIGS. 1A and 1B) on their bottom interior surfaces. Still other tubes for uses referenced herein, as well as for other uses not herein described, can be similarly configured.


The design of the star shaped pattern is important, especially when present in a reagent tube used for recovery of DNA or RNA present in very small quantities (low copy numbers) in a clinical sample, or an extract therefrom. The star-shaped pattern ensures that when a fluid is withdrawn from the tube, a pipette tip can be bottomed out in the tube and still be able to withdraw the entire, or almost the entire fluid from the tube, as shown in FIG. 3, further described herein. This is important because, when working with such small volumes, and when target DNA can be present in very few copies, sample loss due to imperfections of pipetting is to be minimized to every extent possible. Additionally, the stellated pattern should be designed to minimize surface area as well as dead-end grooves that tend to have two undesirable effects: to trap liquid, and to increase undesirable retention of molecules such as polynucleotides by adsorption.


Accordingly, the stellated pattern should enable pipetting of most of the liquid (residual volume<1 microliter) when used with a pipette bottomed out with the bottom of the tube. Although it is not necessary for a pipette tip to bottom out in the reagent tubes described herein, an advantage of it so doing is that a very clear indication of the position of the tip during pipetting is obtained and thereby a consistent positioning can be accomplished across multiple pipetting operations. A requirement that a pipette tip be positioned at some intermediate distance above the bottom of the tube in order to maximize pipetting efficiency, would be harder to verify and to make consistent and reproducible over large numbers of operations even when using an automated pipetting device.


The design of the stellated or star-shaped pattern can be optimized to maximize the flow rate of liquid through various gaps in the pattern that lie between a bottomed out pipette, such as a p1000 pipette, and the star pattern. It would be understood that, although the description herein pertains to pipettes and pipette tips typically used in sample preparation of biological samples, the principles and detailed aspects of the design are as applicable to other types of pipette and pipette tip, and may be so-adapted.



FIG. 1A shows a cross sectional perspective view of a reagent tube 2200 having side wall 2201 and bottom portion 2202. Interior surface 2204 of the bottom portion is visible. An exemplary star-shaped feature 2203 is shown in part, as three apical portions, which may be grooves or may be ridges raised above the lower interior surface 2204. Typically, however, the star-shaped pattern is present as a raised portion on the lower interior surface of the tube.



FIG. 1B shows a plan view of the reagent tube of FIG. 1A, looking down its central axis from the top. Thus wall 2201 in FIG. 1B is shown at its widest diameter, typically corresponding to the top of tube 2200. The exemplary star pattern 2203 shown in FIG. 1B in plan view resembles a “ship's wheel” and comprises a center 2209, a circular ring 2207 centered on center 2209, and eight radial segments 2205 configured as radial ridges or grooves. Each radial segment meets the other radial segment at center 2209, and has a radial end 2206, also referred to as an apex or vertex. Star pattern 2203 in FIG. 1B has eight radial segments, but it would be understood that a star pattern having fewer or a greater number of radial segments, such as 3, 4, 5, 6, 7, 9, 10, or 12, would be consistent with the design herein. The number of radial segments of the star should be a minimum consistent with effective liquid pipetting and ease of manufacture. The radial segments should also be spaced apart enough not to trap the tip of any of the pipette tips to be used in the various liquid handling applications.


Center 2209 is typically positioned coincidentally with the geometric center of the bottom of reagent tube 2200. Such a tube is typically circular in cross-section, so that identifying its geometric center (e.g., at a crossing point of two diameters) is normally straightforward. Center 2209 may be larger than shown in FIG. 1B, such as may be a circular cutout or raised portion that exceeds in diameter the region formed by the meeting point of radial segments 2205.


Ring 2207 is an optional feature of star-shaped pattern 2203. Typically ring 2207 is centered on center 2209, and typically it also has a dimension that corresponds to the lower surface or caliber of a pipette tip. Thus, when a pipette tip ‘bottoms out’ in the bottom of reagent tube 2200, the bottom of the pipette tip rests in contact with ring 2207. Ring 2207 is thus preferably a cut-out or recessed feature that can accommodate the pipette tip and assist in guiding its positioning centrally at the bottom of the tube. Ring 2207 may alternately be a raised or ridge-like feature, according to manufacturing or other preference. In other embodiments more than one, such as 2, 3, or 4, concentric rings 2207 are present, so that pipette tips of varying calibers can be used with the same reagent tube, and each can be suitably positioned, while pipetting, in contact with one of the respective rings.


In the embodiment shown in FIG. 1B, the segments are narrower (occupy a smaller radial angle) than the gaps between them. In other embodiments, the radial segments may be proportionately wider than the gaps between them. When configured as grooves, radial segments 2205 are separated by ridges (occupying the space in between adjacent grooves). In other embodiments, the grooves and ridges that separate them are of equal widths at each radial distance from the center. It may be more appropriate to describe the stellated features as having ridges or • grooves, depending on which occupies the cumulative greater spatial extent.



FIG. 2A shows in cross-sectional plan view a reagent tube 2200 having another exemplary stellated feature 2203, wall 2201, and sealed top 2208. The tube has a cylindrical upper portion 2220, and a tapering lower portion 2202. Shown as a dashed line 2230 in FIG. 2A is a central axis of symmetry of the tube, about which the tube is rotationally symmetric. FIG. 2B shows a top plan view of the reagent tube in FIG. 2A looking down its central axis towards stellated feature 2203 centered in the bottom of the tube. The ring denoted 2202 in FIG. 2B denotes an intermediate diameter of lower portion 2202. Stellated feature 2203 is shown in further detail in FIG. 2C as having 6 radial segments, three adjacent ones of which are labeled 2205-1, 2205-2, and 2205-3, respectively. The axis labeled.X-X′ corresponds to the viewpoint looking into the plane of the page in FIG. 2A. Thus, segment 2205-2 is shown as being in the middle of the stellated feature, and segments 2205-1 and 2205-3 are shown in cross-section, in FIG. 2A.


Characteristic features of the stellated pattern in FIGS. 2A-C include the following: segments 2205 may be configured as grooves or as ridges but are typically ridges, as shown in FIG. 2A; segments 2205 do not meet at center 2209 of the stellated pattern so that, where segments 2205 are ridges, a pipette tip that rests thereupon when pipetting is resting above a space at center 2209; there is no ring corresponding to ring 2207 in FIG. 1B; apices 2206 of segments 2205 are squared off but may be rounded in shape, or may be pointed; segments 2205 have interior apices 2222 that are also rounded, but may be pointed or squared off; and segments 2205 have, in cross-sectional view, rounded or flat bottoms if grooves, or rounded or flat upper surfaces if ridges; segments 2205 may be beveled so that they are narrower in their upper portion than at their lower portion, if ridges, or so that they are narrower in their lower portion than at their upper portion, if grooves.


A star pattern 2203 as described herein is configured to have dimensions that give an optimal flow-rate of liquid out of the reagent tube into a suitably positioned, such as a bottomed-out, pipette tip. The star pattern in FIGS. 1B and 2B is shown as being significantly smaller in diameter than the diameter of the tube at its widest point. The star pattern may have, in various embodiments, a diameter (measured from center 2209 to apex 2206 of a ridge or groove 2205) that is from 1-10%, or from 5-20%, or from 10-25%, or from 15-30%, or from 20-40%, or from 25-50%, or from 30-50%, or from 40-60%, or from 50-75%, or from 65-90% of the maximum diameter of the reagent tube.


The radial segments are typically rounded in their lower surfaces, such as semi-circular in cross section, or having a curved surface that is in cross section an arc of a circle, ellipse, parabola, or hyperbola, but may also be V-shaped. The segments may also be trapezoid in cross-section, such as having a wider upper portion than the bottom, which is flat, the upper portion and the bottom being connected by sloping walls.


In some embodiments, for ease of manufacture, the radial segments end on the same level as one another in the bottom of the tube. Thus the apices 2206 are all disposed on the circumference of a circle whose plane lies perpendicular to the cylindrical axis of the tube. In other embodiments, the segments do not all end on the same level. For example, apices 2206 may alternately be on different levels, and thus the apices are alternately disposed on the respective circumferences of two concentric circles that occupy different, parallel, planes in space from one another.


Radial segments 2205 are shown in FIGS. 1B and 2C as having equal lengths (as measured from center 2209 to apex 2206). This need not be so. In alternative embodiments, segments may have different lengths from one another, for example, as alternating lengths on alternating segments, where there are an even number of segments. Furthermore, apices 2206 may be rounded, rather than pointed, or may be squared off. Typically radial segments 2205 each have a length that is longer than the radius of the inlet hole in the largest pipette tip that is used in connection therewith. Typically radial segments 2205 have a width that is narrower than the diameter of the inlet hole in the largest pipette tip that is used in connection therewith, but it need not be the case.


Typically the radial segments taper uniformly in width and height or depth from center 2209 to each respective apex 2206. Still other configurations are possible, such as a segment that follows a constant width, or depth, out to a particular radial extent, within 30-60% of its length such as near its midpoint of length, and then narrows and/or becomes shallower towards its apex 2206. Alternatively, a radial segment may start narrow at center 2209, widen to a widest region within 30-60% of its length, such as near its midpoint of length, and then narrow towards its apex. Still other possibilities, not described herein, are consistent with the stellated pattern of the reagent tubes herein.


In a 0.3 ml tube, the radius of the star-pattern formed from the radial segments, measured as the shortest distance from center 2209 to an apex 2206, is typically around 0.5 mm, but may be from 0.1-1 mm, or from 0.3-0.7 mm, or from 0.5 to 1.5 mm, or from 0.7 to 2 mm.


In a 0.3 ml tube, the width of each radial segment 2205 at its widest point is typically around 50 microns, and the width typically tapers uniformly from a widest point, closest to or at center 2209, to a narrower width at the apex 2206.


In a 0.3 ml tube, the height (for a ridge) or depth (for a groove) of a segment at the deepest point is typically around 25-50 microns and the height depth typically tapers uniformly from a highest or deepest point respectively, closest to or at center 2209, to an apex 2206.


In another embodiment, in a 0.3 ml tube, the radial segments should be rounded off and less than 100 microns deep (or high), or less than 50 microns deep (or high), or less than 25 microns deep (or high).


The stellated pattern typically has a rotation axis of symmetry, the axis disposed perpendicular to the bottom of the tube and through center 2209 (concentric with a cylindrical axis of the tube), so that the radial segments are disposed symmetrically about the rotation axis. By this is meant that, for n segments, a rotation by an angle of 2π/n about the central (rotational) axis can bring each segment into coincidence with the segment adjacent to it.


The stellated shapes shown in FIGS. 1B and 2B, 2C are not limiting in that they comprise a center, a number of radial segments 2205, and an optional circular ring 2207. Other star-shaped geometries may be used, and, depending upon ease of manufacture and efficacy of use, may be preferred. For example, a star-shaped pattern can be created simply be superimposing two or more polygons having a common center, but offset rotationally with respect to one another by a rotation about the central axis. (See, for example “star polygons” described at the world wide web site mathworld.wolfram.com/StarPolygon.html.) Such alternative manners of creating star-shaped patterns are utilizable herein.


Also shown in the side plan view of FIG. 2A is a top 2208 of tube 2200. Top 2208 is typically made of aluminum foil, which may be heat-sealed on to the top of the tube. Although other layers, or a combination of layers, such as a laminate layer, as further described in U.S. Patent Publication. No. 2009-0129978 A1, filed by ExpressMail on Jul. 14, 2008 (and entitled “Reagent Holder, and Kits Containing Same”, can be placed on top of the reagent tube to seal it, typically a layer of aluminum foil is adequate, where the tube contents are solid, e.g., lyophilized, reagents. In some embodiments, the top of the reagent tube has chamfer edges to reduce expansion of the top rim of the tube during heat sealing of a foil on the top of the tube.


The reagent tube described herein may further comprise an identifiable code, such as a 1-D or a 2-D bar-code on the top 2208. Such a code is useful for identifying the composition of the reagents stored within, and/or a batch number for the preparation thereof, and/or an expiry date. The code may be printed on with, for example, an inkjet or transfer printer. The code may also be attached, or affixed, or printed on, the side of the tube, such as on an exterior surface of wall 2201.


Exemplary Manufacture


A stellated feature such as described herein may be positioned on the interior surface of the bottom of a reagent tube during manufacture of the tube by, for example injection moulding. The stellated feature is typically constructed as a raised feature, proud from the bottom interior surface. Thus, during manufacture of a reagent tube described herein by injection moulding, an outer portion of the mould is a cavity defining the exterior shape of the tube. An interior shape of the tube is formed by an inner portion of the mould positioned concentrically with the outer portion of the mould, and having a star-shaped structure milled out of its tip. Thus, when liquid plastic is injected into the space between the inner and the outer portions of the mould, the star-shape is formed as a raised portion on the bottom interior surface of the tube that is so-formed. Alternately, if the stellated feature is constructed as a recessed feature, the interior portion of the mould will have a complementary stellated feature projecting from its bottom surface.


Reagent tubes may be manufactured by injection moulding in batches, such as via an array of tube-shaped moulds in a single substrate. Tubes made in batch in this way may be imprinted with a non-functional marking characteristic of the location in the array, for example, for purposes of quality control.


Exemplary Pipetting Operations



FIG. 3 has a number of panels, A-G, each representing, in sequence, a stage in a pipetting operation carried out in conjunction with a reagent tube 2200 having a stellated pattern 2203, shown in cross section on the bottom interior surface of the tube 2200 and as further described herein. FIG. 3 is now described, as follows.


At A, a pipette tip 2210, containing a liquid 2211 (such as a buffer solution), is positioned directly or approximately above the center of reagent tube 2200. The tube contains a number of lyophilized pellets 2212, and is sealed by a layer 2214, such as of foil, as further described herein.


At B, the pipette tip is lowered, piercing seal 2214, and brought into a position above the particles 2212.


At C the liquid 2211 is discharged from the pipette tip on to the particles, dissolving the same, as shown at D. After the particles are fully dissolved, forming a solution 2218, the pipette tip is lowered to a position where it is in contact with the stellated pattern 2203.


At E, the pipette tip is caused to suck up the solution 2218 (typically leaving less than 1 μl of solution 2218 in the tube), and at F, the tip may optionally discharge the solution back into the tube. Steps E and F may be repeated, as desired, to facilitate dissolution and mixing of the lyophilized components into solution.


At G, after sucking up as much of the solution 2218 as is practicable into the pipette tip, the pipette tip is withdrawn from the tube. Ideally, 100% by volume of the solution 2218 is drawn up into the pipette tip at G. In other embodiments, and depending upon the nature of solution 2218, at least 99% by volume of the solution is drawn up. In still other embodiments, at least 98%, at least 97%, at least 96%, at least 95%, and at least 90% by volume of the solution is drawn up.


The following examples illustrate an embodiment of the invention described and claimed herein, and are not intended to be limiting.


EXAMPLES
Example 1
Reagent Tube

An exemplary reagent tube, showing various dimensions, is shown in FIGS. 4A-4D. Tolerances on the shown dimensions, during manufacture, are as follows: features≦0.5 inches are machined to within±0.010 inches; features<0.5 inches are machined to within±0.005 inches; feature locations, such as theoretical center points and theoretical center lines, are within±0.010 inches of those shown in the drawings. It is to be understood that dimensions can also be represented in their metric system equivalents without departing from the scope of the technology herein.


The cross-hatch area shown on the upper portion of the tube in FIG. 4C is an area on which a marking may be made, such as during manufacture, for the purpose of indicating product origin, identifying the batch, or for quality control.


The pattern of ridges shown in FIG. 4D is such that each ridge comprise a rectangular portion capped by a semi-circular arc, the semi-circular arc being disposed close to the common center of the pattern of ridges and having a diameter of 0.203 mm. In the embodiment shown in FIG. 4D, the distance from the center of the circle of which the semi-circular arc is formed to the center of the pattern is 0.381 mm.


The tube is made from polypropylene homopolymer, e.g., available from Cannel Olefins Ltd., and identified as product no. Capilene U77 AV (see, e.g., world wide web site carmel-olefins.co.il/Media/Uploads/Capilene_nomenclatur.pdf).


Surfaces are SPI (Society of the Plastics Industry) grade A-2, a known surface quality measurement, or better.


Any and all flashes and burrs resulting from the manufacture are removed and, in order to be used, the tube should not come into contact with grease, dust, mold release or other foreign substances. The tube should also be free of cracks, crazing, scratches, and internal defects or particulates obvious to the unaided eye.


Example 2
Foil Piercing and Dissolution of Lyophilized Reagents

The containers of lyophilized reagents provided in conjunction with a holder as described herein are typically sealed by a non-plasticized aluminum foil. Aluminum foil bursts into an irregular polygonal pattern when pierced through a pipette and leaves an air vent even though the pipette is moved to the bottom of the tube. In order to save on reagents, it is desirable to dissolve the reagents and maximize the amount withdrawn from the tube. To accomplish this, a ridged-star (stellated) pattern is placed at the bottom of the container to maximize liquid volume withdrawn, and flow velocity in between the ridges.


Exemplary steps for dissolving solid particles, and withdrawing fluid are as follows:

    • 1. Pierce through the pipette and dispense the fluid away from the lyophilized material. If the pipette goes below the level of the lyophilized material, it will go into the pipette and may cause jamming of the liquid flow out of the pipette.
    • 2. Let the lyophilized material dissolve for a few seconds.
    • 3. Move pipette down touching the ridged-bottom of the tube.
    • 4. Perform an adequate number of suck and spit operations (4-10) to thoroughly mix the reagents with the liquid buffer.
    • 5. Withdraw all the reagents and move pipette to dispense it into the next processing tube.


The foregoing description is intended to illustrate various aspects of the present inventions. It is not intended that the examples presented herein limit the scope of the present inventions. The technology now being fully described, it will be apparent to one of ordinary skill in the art that many changes and modifications can be made thereto without departing from the spirit or scope of the appended claims.

Claims
  • 1. A reagent tube for insertion into a tube holder strip, comprising: a tube body having a top, a bottom, and an interior surface, wherein the top, bottom, and interior surface of the tube body define a volume configured to hold a liquid;a radially-extending lip at the top of the tube body configured for locking engagement with cooperating structure on a tube holder strip to retain the tube after insertion into a tube holder strip;a pattern of convex ridges extending radially and centered at the bottom of the interior surface of the tube, wherein the convex ridges extend vertically from the bottom interior surface of the tube body, wherein the pattern of ridges and the ridges are configured to enable pipetting of substantially all of the liquid held in the reagent tube; anda ring centered at the bottom of the interior surface of the tube, wherein the pattern of radially extending convex ridges intersect the ring.
  • 2. The tube of claim 1, wherein the number of ridges is selected from 3, 4, 5, 6, 8, 9, 10, or 12.
  • 3. The tube of claim 1, wherein the ridges do not meet one another at a center of the pattern.
  • 4. The tube of claim 1, wherein each of the ridges has a width, wherein the width tapers from a widest point to an apex.
  • 5. The tube of claim 4, wherein the widest point has a width of 50 microns.
  • 6. The tube of claim 1, wherein each of the ridges has a height, wherein the height tapers from a highest point to an apex.
  • 7. The tube of claim 1, wherein each of the ridges has a length, measured as the shortest distance from its widest point to its apex.
  • 8. The tube of claim 6, wherein the length is 0.5 mm.
  • 9. The tube of claim 1, having a volume of 0.3 ml.
  • 10. The tube of claim 1, having a volume of between 0.1 ml to 0.65 ml.
  • 11. The reagent tube of claim 1, where the top of the reagent tube has chamfer edges to reduce expansion of the top rim of the tube during heat sealing of a foil on the top of the tube.
  • 12. The reagent tube of claim 1, further comprising a reagent contained therein, and wherein the tube is sealed on top by a foil.
  • 13. The reagent tube of claim 12, further comprising an identifiable code on the top.
  • 14. The reagent tube of claim 12, wherein the reagent is in liquid or lyophilized form.
  • 15. The tube of claim 1, wherein the pattern of ridges extending radially and centered at the bottom of the interior surface of the tube is a stellated pattern.
  • 16. The tube of claim 15, wherein each of the ridges has a width, wherein the width tapers from a widest point to an apex.
  • 17. The tube of claim 15, wherein each of the ridges has a height, wherein the height tapers from a widest point to an apex.
  • 18. The tube of claim 15, wherein the stellated pattern has a rotation axis of symmetry, the axis disposed perpendicular to the bottom of the tube, and wherein the ridges are disposed symmetrically about the rotation axis.
  • 19. The tube of claim 15, wherein the stellated pattern additionally comprises a circular cutout at the center of the bottom of the tube.
  • 20. The reagent tube of claim 15, wherein the stellated pattern is designed to enable liquid to be pipetted out of the tube, with less than 1 microliter of residual volume.
  • 21. The tube of claim 16, wherein the widest point is closest to a center of the stellated pattern.
  • 22. The tube of claim 17, wherein the highest point is closest to a center of the stellated pattern.
  • 23. The tube of claim 22, wherein the highest point has a height of 25-30 microns.
  • 24. A reagent holding system, comprising: a reagent tube, comprising: a tube body having a top, a bottom, and an interior surface, wherein the top, bottom, and interior surface of the tube body define a volume configured to hold a liquid;a radially-extending lip at the top of the tube body;a pattern of convex ridges extending radially and centered at the bottom of the interior surface of the tube, wherein the convex ridges extend vertically from the bottom interior surface of the tube body, wherein the pattern of ridges and the ridges are configured to enable pipetting of substantially all of the liquid held in the reagent tube; anda ring centered at the bottom of the interior surface of the tube, wherein the pattern of radially extending convex ridges intersect the ring; anda tube-holding strip having an opening for receiving the reagent tube with a cooperating structure configured for locking engagement with the lip of the tube body after insertion of the tube body into the tube holder strip.
  • 25. The reagent holding system of claim 24, wherein the ridges do not meet one another at a center of the pattern.
  • 26. The reagent holding system of claim 24, wherein the top of the reagent tube has chamfer edges to reduce expansion of the top rim of the tube during heat sealing of a foil on the top of the tube.
  • 27. The reagent holding system of claim 24, wherein the cooperating structure comprises a snap tab.
  • 28. A reagent tube for insertion into a tube holder strip, comprising: a tube body having a top, a bottom, and an interior surface, wherein the top, bottom, and interior surface of the tube body define a volume configured to hold a liquid;a radially-extending lip configured for locking engagement with cooperating structure on a tube holder strip to retain the tube after insertion into the tube holder strip, the lip comprising a top surface proximal to the top of the tube body, a bottom surface opposite the top surface, a radial wall extending between the top and bottom surface of the lip, and a beveled edge located at the junction of the top surface and the radial wall;a pattern of convex ridges extending radially and centered at the bottom of the interior surface of the tube, wherein the convex ridges extend vertically from the bottom interior surface of the tube body, wherein the pattern of ridges and the ridges are configured to enable pipetting of substantially all of the liquid held in the reagent tube; anda ring centered at the bottom of the interior surface of the tube, wherein the pattern of radially extending convex ridges intersect the ring.
  • 29. The tube of claim 27, wherein the ridges do not meet one another at a center of the pattern.
  • 30. The reagent tube of claim 27, where the top of the reagent tube has chamfer edges to reduce expansion of the top rim of the tube during heat sealing of a foil on the top of the tube.
  • 31. The reagent tube of claim 27, wherein the width of the radial lip is at least twice as large as the thickness of the radial lip.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/178,557, filed on Jul. 23, 2008 which is a continuation-in-part of each of U.S. patent application Ser. No. 12/218,498, filed on Jul. 14, 2008, U.S. patent application Ser. No. 12/218,416, filed on Jul. 14, 2008, and U.S. patent application Ser. No. 12/173,023, filed Jul. 14, 2008, each of which claims the benefit of priority to U.S. provisional Patent Application Ser. No. 60/959,437, filed Jul. 13, 2007. All of the above patent applications are incorporated herein by reference in their entireties.

US Referenced Citations (701)
Number Name Date Kind
1434314 Raich Oct 1922 A
1616419 Wilson Feb 1927 A
1733401 Lovekin Aug 1930 A
3528449 Witte et al. Sep 1970 A
3985649 Eddelman Oct 1976 A
4018089 Dzula et al. Apr 1977 A
4018652 Lanham et al. Apr 1977 A
4038192 Serur Jul 1977 A
4055395 Honkawa et al. Oct 1977 A
D249706 Adamski Sep 1978 S
4139005 Dickey Feb 1979 A
D252157 Kronish et al. Jun 1979 S
D252341 Thomas Jul 1979 S
D254687 Fadler et al. Apr 1980 S
4212744 Oota Jul 1980 A
D261033 Armbruster Sep 1981 S
D261173 Armbruster Oct 1981 S
4301412 Hill et al. Nov 1981 A
4439526 Columbus Mar 1984 A
4457329 Werley et al. Jul 1984 A
4466740 Kano et al. Aug 1984 A
4504582 Swann Mar 1985 A
4522786 Ebersole Jun 1985 A
D279817 Chen et al. Jul 1985 S
4599315 Terasaki et al. Jul 1986 A
4612873 Gunter Sep 1986 A
4612959 Costello Sep 1986 A
D288478 Carlson et al. Feb 1987 S
4654127 Baker et al. Mar 1987 A
4673657 Christian Jun 1987 A
4683195 Mullis et al. Jul 1987 A
4683202 Mullis Jul 1987 A
D292735 Lovborg Nov 1987 S
4720374 Ramachandran Jan 1988 A
4798693 Mase et al. Jan 1989 A
4800022 Leonard Jan 1989 A
4841786 Schulz Jun 1989 A
D302294 Hillman Jul 1989 S
4895650 Wang Jan 1990 A
4919829 Gates et al. Apr 1990 A
4921809 Schiff et al. May 1990 A
4935342 Seligson et al. Jun 1990 A
4946562 Guruswamy Aug 1990 A
4949742 Rando et al. Aug 1990 A
D310413 Bigler et al. Sep 1990 S
4963498 Hillman Oct 1990 A
4967950 Legg et al. Nov 1990 A
4978502 Dole et al. Dec 1990 A
4978622 Mishell et al. Dec 1990 A
4989626 Takagi et al. Feb 1991 A
5001417 Pumphrey et al. Mar 1991 A
5004583 Guruswamy et al. Apr 1991 A
5048554 Kremer Sep 1991 A
5053199 Keiser et al. Oct 1991 A
5060823 Perlman Oct 1991 A
5061336 Soane Oct 1991 A
5064618 Baker et al. Nov 1991 A
5071531 Soane Dec 1991 A
5091328 Miller Feb 1992 A
D324426 Fan et al. Mar 1992 S
5096669 Lauks et al. Mar 1992 A
5126002 Iwata et al. Jun 1992 A
5126022 Soane et al. Jun 1992 A
D328135 Fan et al. Jul 1992 S
D328794 Frenkel et al. Aug 1992 S
5135627 Soane Aug 1992 A
5135872 Pouletty et al. Aug 1992 A
5147606 Charlton et al. Sep 1992 A
5169512 Wiedenmann et al. Dec 1992 A
D333522 Gianino Feb 1993 S
5186339 Heissler Feb 1993 A
5192507 Taylor et al. Mar 1993 A
5208163 Charlton et al. May 1993 A
5223226 Wittmer et al. Jun 1993 A
D338275 Fischer et al. Aug 1993 S
5250263 Manz Oct 1993 A
5252743 Barrett et al. Oct 1993 A
5256376 Callan et al. Oct 1993 A
5275787 Yuguchi et al. Jan 1994 A
5282950 Dietze et al. Feb 1994 A
5296375 Kricka et al. Mar 1994 A
5304477 Nagoh et al. Apr 1994 A
5304487 Wilding et al. Apr 1994 A
D347478 Pinkney May 1994 S
5311896 Kaartinen et al. May 1994 A
5311996 Duffy et al. May 1994 A
5316727 Suzuki et al. May 1994 A
5327038 Culp Jul 1994 A
5339486 Persic, Jr. Aug 1994 A
D351475 Gerber Oct 1994 S
D351913 Hieb et al. Oct 1994 S
5364591 Green et al. Nov 1994 A
5372946 Cusak et al. Dec 1994 A
5374395 Robinson Dec 1994 A
5389339 Petschek et al. Feb 1995 A
5397709 Berndt Mar 1995 A
5401465 Smethers et al. Mar 1995 A
5411708 Moscetta et al. May 1995 A
5414245 Hackleman May 1995 A
5416000 Allen et al. May 1995 A
5422271 Chen et al. Jun 1995 A
5422284 Lau Jun 1995 A
5427946 Kricka et al. Jun 1995 A
5474796 Brennan Dec 1995 A
D366116 Biskupski Jan 1996 S
5486335 Wilding et al. Jan 1996 A
5494639 Grzegorzewski Feb 1996 A
5498392 Wilding et al. Mar 1996 A
5503803 Brown Apr 1996 A
5516410 Schneider et al. May 1996 A
5519635 Miyake et al. May 1996 A
5529677 Schneider et al. Jun 1996 A
5559432 Logue Sep 1996 A
5565171 Dovichi et al. Oct 1996 A
5569364 Hooper et al. Oct 1996 A
5578818 Kain et al. Nov 1996 A
5579928 Anukwuem Dec 1996 A
5580523 Bard Dec 1996 A
5582884 Ball et al. Dec 1996 A
5585069 Zanzucchi et al. Dec 1996 A
5585089 Queen et al. Dec 1996 A
5585242 Bouma et al. Dec 1996 A
5587128 Wilding et al. Dec 1996 A
5589136 Northrup et al. Dec 1996 A
5593838 Zanzucchi et al. Jan 1997 A
5595708 Berndt Jan 1997 A
5599432 Manz et al. Feb 1997 A
5599503 Manz et al. Feb 1997 A
5599667 Arnold, Jr. et al. Feb 1997 A
5601727 Bormann et al. Feb 1997 A
5603351 Cherukuri et al. Feb 1997 A
5605662 Heller et al. Feb 1997 A
D378782 LaBarbera et al. Apr 1997 S
5628890 Carter et al. May 1997 A
5630920 Friese et al. May 1997 A
5631337 Sassi et al. May 1997 A
5632876 Zanzucchi et al. May 1997 A
5632957 Heller et al. May 1997 A
5635358 Wilding et al. Jun 1997 A
5637469 Wilding et al. Jun 1997 A
5639423 Northrup et al. Jun 1997 A
5643738 Zanzucchi et al. Jul 1997 A
5646039 Northrup et al. Jul 1997 A
5647994 Tuunanen et al. Jul 1997 A
5651839 Rauf Jul 1997 A
5652149 Mileaf et al. Jul 1997 A
D382346 Buhler et al. Aug 1997 S
D382647 Staples et al. Aug 1997 S
5667976 Van Ness et al. Sep 1997 A
5671303 Shieh et al. Sep 1997 A
5674394 Whitmore Oct 1997 A
5674742 Northrup et al. Oct 1997 A
5681484 Zanzucchi et al. Oct 1997 A
5681529 Taguchi et al. Oct 1997 A
5683657 Mian Nov 1997 A
5699157 Parce Dec 1997 A
5700637 Southern Dec 1997 A
5705813 Apffel et al. Jan 1998 A
5726026 Wilding et al. Mar 1998 A
5726404 Brody Mar 1998 A
5726944 Taft et al. Mar 1998 A
5731212 Gavin et al. Mar 1998 A
5744366 Kricka et al. Apr 1998 A
5747666 Willis May 1998 A
5750015 Soane et al. May 1998 A
5755942 Zanzucchi et al. May 1998 A
5763262 Wong et al. Jun 1998 A
5770029 Nelson et al. Jun 1998 A
5770388 Vorpahl Jun 1998 A
5772966 Maracas et al. Jun 1998 A
5779868 Parce et al. Jul 1998 A
5787032 Heller et al. Jul 1998 A
5788814 Sun et al. Aug 1998 A
5800690 Chow et al. Sep 1998 A
5804436 Okun et al. Sep 1998 A
D399959 Prokop et al. Oct 1998 S
5827481 Bente et al. Oct 1998 A
5842106 Thaler et al. Nov 1998 A
5842787 Kopf-Sill et al. Dec 1998 A
5846396 Zanzucchi et al. Dec 1998 A
5849208 Hayes et al. Dec 1998 A
5849486 Heller et al. Dec 1998 A
5849489 Heller Dec 1998 A
5849598 Wilson et al. Dec 1998 A
5852495 Parce Dec 1998 A
5856174 Lipshutz et al. Jan 1999 A
5858187 Ramsey et al. Jan 1999 A
5858188 Soane et al. Jan 1999 A
5863502 Southgate et al. Jan 1999 A
5863708 Zanzucchi et al. Jan 1999 A
5863801 Southgate et al. Jan 1999 A
5866345 Wilding et al. Feb 1999 A
5869004 Parce et al. Feb 1999 A
5872010 Karger et al. Feb 1999 A
5872623 Stabile et al. Feb 1999 A
5874046 Megerle Feb 1999 A
5876675 Kennedy Mar 1999 A
5880071 Parce et al. Mar 1999 A
5882465 McReynolds Mar 1999 A
5883211 Sassi et al. Mar 1999 A
5885432 Hooper et al. Mar 1999 A
5885470 Parce et al. Mar 1999 A
5895762 Greenfield et al. Apr 1999 A
5900130 Benregnu et al. May 1999 A
5912124 Kumar Jun 1999 A
5912134 Shartle Jun 1999 A
5916522 Boyd et al. Jun 1999 A
5916776 Kumar Jun 1999 A
5919646 Okun et al. Jul 1999 A
5919711 Boyd et al. Jul 1999 A
5922591 Anderson et al. Jul 1999 A
5927547 Papen et al. Jul 1999 A
5928880 Wilding et al. Jul 1999 A
5929208 Heller et al. Jul 1999 A
D413391 Lapeus et al. Aug 1999 S
5932799 Moles Aug 1999 A
5935401 Amigo Aug 1999 A
5939291 Loewy et al. Aug 1999 A
5942443 Parce et al. Aug 1999 A
D413677 Dumitrescu et al. Sep 1999 S
5948227 Dubrow Sep 1999 A
5955028 Chow Sep 1999 A
5955029 Wilding et al. Sep 1999 A
5957579 Kopf-Sill et al. Sep 1999 A
5958203 Parce et al. Sep 1999 A
5958694 Nikiforov Sep 1999 A
5959221 Boyd et al. Sep 1999 A
5959291 Jensen Sep 1999 A
5964995 Nikiforov et al. Oct 1999 A
5964997 McBride Oct 1999 A
5965001 Chow et al. Oct 1999 A
5965410 Chow et al. Oct 1999 A
5965886 Sauer et al. Oct 1999 A
5972187 Parce et al. Oct 1999 A
5973138 Collis Oct 1999 A
D417009 Boyd Nov 1999 S
5976336 Dubrow et al. Nov 1999 A
5980704 Cherukuri et al. Nov 1999 A
5980719 Cherukuri et al. Nov 1999 A
5981735 Thatcher et al. Nov 1999 A
5989402 Chow et al. Nov 1999 A
5992820 Fare et al. Nov 1999 A
5993611 Moroney, III et al. Nov 1999 A
5993750 Ghosh et al. Nov 1999 A
5997708 Craig Dec 1999 A
6001229 Ramsey Dec 1999 A
6001231 Kopf-Sill Dec 1999 A
6001307 Naka et al. Dec 1999 A
6004515 Parce et al. Dec 1999 A
6007690 Nelson et al. Dec 1999 A
6010607 Ramsey Jan 2000 A
6010608 Ramsey Jan 2000 A
6010627 Hood, III Jan 2000 A
6012902 Parce Jan 2000 A
D420747 Dumitrescu et al. Feb 2000 S
D421130 Cohen et al. Feb 2000 S
6024920 Cunanan Feb 2000 A
D421653 Purcell Mar 2000 S
6033546 Ramsey Mar 2000 A
6043080 Lipshutz et al. Mar 2000 A
6046056 Parce et al. Apr 2000 A
6048734 Burns et al. Apr 2000 A
6054034 Soane et al. Apr 2000 A
6054277 Furcht et al. Apr 2000 A
6056860 Amigo et al. May 2000 A
6057149 Burns et al. May 2000 A
6062261 Jacobson et al. May 2000 A
6063341 Fassbind et al. May 2000 A
6063589 Kellogg et al. May 2000 A
6071478 Chow Jun 2000 A
6074725 Kennedy Jun 2000 A
6074827 Nelson et al. Jun 2000 A
D428497 Lapeus et al. Jul 2000 S
6086740 Kennedy Jul 2000 A
6096509 Okun et al. Aug 2000 A
6100541 Nagle et al. Aug 2000 A
6102897 Lang Aug 2000 A
6103537 Ullman et al. Aug 2000 A
6106685 McBride et al. Aug 2000 A
6110343 Ramsey et al. Aug 2000 A
6123205 Dumitrescu et al. Sep 2000 A
6123798 Gandhi et al. Sep 2000 A
6130098 Handique et al. Oct 2000 A
6132580 Mathies et al. Oct 2000 A
6132684 Marino Oct 2000 A
6133436 Koster et al. Oct 2000 A
D433759 Mathis et al. Nov 2000 S
6143250 Tajima Nov 2000 A
6149787 Chow et al. Nov 2000 A
6156199 Zuk, Jr. Dec 2000 A
6158269 Dorenkott et al. Dec 2000 A
6167910 Chow Jan 2001 B1
6168948 Anderson et al. Jan 2001 B1
6171850 Nagle et al. Jan 2001 B1
6174675 Chow et al. Jan 2001 B1
D438311 Yamanishi et al. Feb 2001 S
6190619 Kilcoin et al. Feb 2001 B1
D438632 Miller Mar 2001 S
D438633 Miller Mar 2001 S
6197595 Anderson et al. Mar 2001 B1
6211989 Wulf et al. Apr 2001 B1
6213151 Jacobson et al. Apr 2001 B1
6221600 MacLeod et al. Apr 2001 B1
6228635 Armstrong et al. May 2001 B1
6235175 Dubrow et al. May 2001 B1
6235313 Mathiowitz et al. May 2001 B1
6235471 Knapp et al. May 2001 B1
6236581 Foss et al. May 2001 B1
6251343 Dubrow et al. Jun 2001 B1
6254826 Acosta et al. Jul 2001 B1
6259635 Torelli et al. Jul 2001 B1
6261431 Mathies et al. Jul 2001 B1
6267858 Parce et al. Jul 2001 B1
D446306 Ochi et al. Aug 2001 S
6271021 Burns et al. Aug 2001 B1
6274089 Chow et al. Aug 2001 B1
6280967 Ransom et al. Aug 2001 B1
6281008 Komai et al. Aug 2001 B1
6284113 Bjornson et al. Sep 2001 B1
6287254 Dodds Sep 2001 B1
6287774 Kikiforov Sep 2001 B1
6291248 Haj-Ahmad Sep 2001 B1
6294063 Becker et al. Sep 2001 B1
6302134 Kellogg et al. Oct 2001 B1
6302304 Spencer Oct 2001 B1
6303343 Kopf-sill Oct 2001 B1
6306273 Wainright et al. Oct 2001 B1
6306590 Mehta et al. Oct 2001 B1
6319469 Mian et al. Nov 2001 B1
6322683 Wolk et al. Nov 2001 B1
6326083 Yang et al. Dec 2001 B1
6326211 Anderson et al. Dec 2001 B1
6337435 Chu et al. Jan 2002 B1
6353475 Jensen et al. Mar 2002 B1
6358387 Kopf-sill et al. Mar 2002 B1
6366924 Parce Apr 2002 B1
6368871 Christel et al. Apr 2002 B1
6370206 Schenk Apr 2002 B1
6375185 Lin Apr 2002 B1
6375901 Robotti et al. Apr 2002 B1
6379884 Wada et al. Apr 2002 B2
6379929 Burns et al. Apr 2002 B1
6379974 Parce et al. Apr 2002 B1
6391541 Petersen et al. May 2002 B1
6391623 Besemer et al. May 2002 B1
6395161 Schneider et al. May 2002 B1
6398956 Coville et al. Jun 2002 B1
6399025 Chow Jun 2002 B1
6399389 Parce et al. Jun 2002 B1
6399952 Maher et al. Jun 2002 B1
6403338 Knapp et al. Jun 2002 B1
6408878 Unger et al. Jun 2002 B2
6413401 Chow et al. Jul 2002 B1
6416642 Alajoki et al. Jul 2002 B1
6420143 Kopf-sill Jul 2002 B1
6425972 McReynolds Jul 2002 B1
D461906 Pham Aug 2002 S
6428987 Franzen Aug 2002 B2
6430512 Gallagher Aug 2002 B1
6432366 Ruediger et al. Aug 2002 B2
6440725 Pourahmadi et al. Aug 2002 B1
D463031 Slomski et al. Sep 2002 S
6444461 Knapp et al. Sep 2002 B1
6447661 Chow et al. Sep 2002 B1
6447727 Parce et al. Sep 2002 B1
6448064 Vo-Dinh et al. Sep 2002 B1
6453928 Kaplan et al. Sep 2002 B1
6465257 Parce et al. Oct 2002 B1
6468761 Yang et al. Oct 2002 B2
6472141 Nikiforov Oct 2002 B2
6475364 Dubrow et al. Nov 2002 B1
D467348 McMichael et al. Dec 2002 S
D467349 Niedbala et al. Dec 2002 S
6488897 Dubrow et al. Dec 2002 B2
6495104 Unno et al. Dec 2002 B1
6498497 Chow et al. Dec 2002 B1
6500323 Chow et al. Dec 2002 B1
6500390 Boulton et al. Dec 2002 B1
D468437 McMenamy et al. Jan 2003 S
6506609 Wada et al. Jan 2003 B1
6509193 Tajima Jan 2003 B1
6511853 Kopf-sill et al. Jan 2003 B1
D470595 Crisanti et al. Feb 2003 S
6515753 Maher Feb 2003 B2
6517783 Horner et al. Feb 2003 B2
6520197 Deshmukh et al. Feb 2003 B2
6521188 Webster Feb 2003 B1
6524456 Ramsey et al. Feb 2003 B1
6524790 Kopf-sill et al. Feb 2003 B1
D472324 Rumore et al. Mar 2003 S
6534295 Tai et al. Mar 2003 B2
6537771 Farinas et al. Mar 2003 B1
6540896 Manz et al. Apr 2003 B1
6544734 Briscoe et al. Apr 2003 B1
6547942 Parce et al. Apr 2003 B1
6555389 Ullman et al. Apr 2003 B1
6556923 Gallagher et al. Apr 2003 B2
D474279 Mayer et al. May 2003 S
D474280 Niedbala et al. May 2003 S
6558916 Veerapandian et al. May 2003 B2
6558945 Kao May 2003 B1
6569607 Mcreynolds May 2003 B2
6572830 Burdon et al. Jun 2003 B1
6575188 Parunak Jun 2003 B2
6576459 Miles et al. Jun 2003 B2
6579453 Bächler et al. Jun 2003 B1
6589729 Chan et al. Jul 2003 B2
6592821 Wada et al. Jul 2003 B1
6597450 Andrews et al. Jul 2003 B1
6602474 Tajima Aug 2003 B1
6613211 Mccormick et al. Sep 2003 B1
6613512 Kopf-sill et al. Sep 2003 B1
6613580 Chow et al. Sep 2003 B1
6613581 Wada et al. Sep 2003 B1
6614030 Maher et al. Sep 2003 B2
6620625 Wolk et al. Sep 2003 B2
6623860 Hu et al. Sep 2003 B2
6627406 Singh et al. Sep 2003 B1
D480814 Lafferty et al. Oct 2003 S
6632655 Mehta et al. Oct 2003 B1
D482796 Oyama et al. Nov 2003 S
6649358 Parce et al. Nov 2003 B1
6664104 Pourahmadi et al. Dec 2003 B2
6669831 Chow et al. Dec 2003 B2
6670153 Stern Dec 2003 B2
D484989 Gebrian Jan 2004 S
6681616 Spaid et al. Jan 2004 B2
6681788 Parce et al. Jan 2004 B2
6685813 Williams et al. Feb 2004 B2
6692700 Handique Feb 2004 B2
6695009 Chien et al. Feb 2004 B2
6706519 Kellogg et al. Mar 2004 B1
6720148 Nikiforov Apr 2004 B1
6730206 Ricco et al. May 2004 B2
6733645 Chow May 2004 B1
6734401 Bedingham et al. May 2004 B2
D491272 Alden et al. Jun 2004 S
D491273 Biegler et al. Jun 2004 S
D491276 Langille Jun 2004 S
6750661 Brooks et al. Jun 2004 B2
6752966 Chazan Jun 2004 B1
6756019 Dubrow et al. Jun 2004 B1
6766817 da Silva Jul 2004 B2
6773567 Wolk Aug 2004 B1
6777184 Nikiforov et al. Aug 2004 B2
6783962 Olander et al. Aug 2004 B1
D495805 Lea et al. Sep 2004 S
6787015 Lackritz et al. Sep 2004 B2
6787016 Tan et al. Sep 2004 B2
6790328 Jacobson et al. Sep 2004 B2
6790330 Gascoyne et al. Sep 2004 B2
6811668 Berndt et al. Nov 2004 B1
6818113 Williams et al. Nov 2004 B2
6819027 Saraf Nov 2004 B2
6824663 Boone Nov 2004 B1
D499813 Wu Dec 2004 S
D500142 Crisanti et al. Dec 2004 S
6827831 Chow et al. Dec 2004 B1
6827906 Bjornson et al. Dec 2004 B1
6838156 Neyer et al. Jan 2005 B1
6838680 Maher et al. Jan 2005 B2
6852287 Ganesan Feb 2005 B2
6858185 Kopf-sill et al. Feb 2005 B1
6859698 Schmeisser Feb 2005 B2
6861035 Pham et al. Mar 2005 B2
6878540 Pourahmadi et al. Apr 2005 B2
6878755 Singh et al. Apr 2005 B2
6884628 Hubbell et al. Apr 2005 B2
6887693 McMillan et al. May 2005 B2
6893879 Petersen et al. May 2005 B2
6900889 Bjornson et al. May 2005 B2
6905583 Wainright et al. Jun 2005 B2
6905612 Dorian et al. Jun 2005 B2
6906797 Kao et al. Jun 2005 B1
6908594 Schaevitz et al. Jun 2005 B1
6911183 Handique et al. Jun 2005 B1
6914137 Baker Jul 2005 B2
6915679 Chien et al. Jul 2005 B2
6918404 da Silva Jul 2005 B2
D508999 Fanning et al. Aug 2005 S
6939451 Zhao et al. Sep 2005 B2
6942771 Kayyem Sep 2005 B1
6958392 Fomovskaia et al. Oct 2005 B2
D512155 Matsumoto Nov 2005 S
6964747 Banerjee et al. Nov 2005 B2
6977163 Mehta Dec 2005 B1
6984516 Briscoe et al. Jan 2006 B2
D515707 Shinohara et al. Feb 2006 S
D516221 Wohlstadter et al. Feb 2006 S
7001853 Brown et al. Feb 2006 B1
7004184 Handique et al. Feb 2006 B2
D517554 Yanagisawa et al. Mar 2006 S
7010391 Handique et al. Mar 2006 B2
7023007 Gallagher Apr 2006 B2
7024281 Unno Apr 2006 B1
7036667 Greenstein et al. May 2006 B2
7037416 Parce et al. May 2006 B2
7038472 Chien May 2006 B1
7039527 Tripathi et al. May 2006 B2
7040144 Spaid et al. May 2006 B2
D523153 Akashi et al. Jun 2006 S
7055695 Greenstein et al. Jun 2006 B2
7060171 Nikiforov et al. Jun 2006 B1
7066586 da Silva Jun 2006 B2
7069952 Mcreynolds et al. Jul 2006 B1
7099778 Chien Aug 2006 B2
D528215 Malmsater Sep 2006 S
7101467 Spaid Sep 2006 B2
7105304 Nikiforov et al. Sep 2006 B1
D531321 Godfrey et al. Oct 2006 S
7118910 Unger et al. Oct 2006 B2
7138032 Gandhi et al. Nov 2006 B2
D534280 Gomm et al. Dec 2006 S
7148043 Kordunsky et al. Dec 2006 B2
7150814 Parce et al. Dec 2006 B1
7150999 Shuck Dec 2006 B1
D535403 Isozaki et al. Jan 2007 S
7160423 Chien et al. Jan 2007 B2
7161356 Chien Jan 2007 B1
7169277 Ausserer et al. Jan 2007 B2
7169618 Skould Jan 2007 B2
D537951 Okamoto et al. Mar 2007 S
D538436 Patadia et al. Mar 2007 S
7192557 Wu et al. Mar 2007 B2
7195986 Bousse et al. Mar 2007 B1
7208125 Dong Apr 2007 B1
7235406 Woudenberg et al. Jun 2007 B1
7247274 Chow Jul 2007 B1
D548841 Brownell et al. Aug 2007 S
D549827 Maeno et al. Aug 2007 S
7252928 Hafeman et al. Aug 2007 B1
7270786 Parunak et al. Sep 2007 B2
D554069 Bolotin et al. Oct 2007 S
D554070 Bolotin et al. Oct 2007 S
7276330 Chow et al. Oct 2007 B2
D556914 Okamoto et al. Dec 2007 S
7303727 Dubrow et al. Dec 2007 B1
D559995 Handique et al. Jan 2008 S
7323140 Handique et al. Jan 2008 B2
7332130 Handique Feb 2008 B2
7338760 Gong et al. Mar 2008 B2
D566291 Parunak et al. Apr 2008 S
7351377 Chazan et al. Apr 2008 B2
D569526 Duffy et al. May 2008 S
7374949 Kuriger May 2008 B2
7390460 Osawa et al. Jun 2008 B2
7419784 Dubrow et al. Sep 2008 B2
7422669 Jacobson et al. Sep 2008 B2
7440684 Spaid et al. Oct 2008 B2
7476313 Siddiqi Jan 2009 B2
7494577 Williams et al. Feb 2009 B2
7494770 Wilding et al. Feb 2009 B2
7514046 Kechagia et al. Apr 2009 B2
7518726 Rulison et al. Apr 2009 B2
7521186 Mehta Apr 2009 B2
7527769 Bunch et al. May 2009 B2
7553671 Sinclair et al. Jun 2009 B2
D596312 Giraud et al. Jul 2009 S
7595197 Brasseur Sep 2009 B2
7604938 Takahashi et al. Oct 2009 B2
7635588 King et al. Dec 2009 B2
7645581 Knapp et al. Jan 2010 B2
7670559 Chien et al. Mar 2010 B2
7704735 Facer et al. Apr 2010 B2
7723123 Murphy et al. May 2010 B1
D618820 Wilson et al. Jun 2010 S
7727371 Kennedy et al. Jun 2010 B2
7727477 Boronkay et al. Jun 2010 B2
7744817 Bui Jun 2010 B2
D621060 Handique Aug 2010 S
7867776 Kennedy et al. Jan 2011 B2
7892819 Wilding et al. Feb 2011 B2
20010023848 Gjerde et al. Sep 2001 A1
20010038450 McCaffrey et al. Nov 2001 A1
20010046702 Schembri Nov 2001 A1
20010055765 O'Keefe et al. Dec 2001 A1
20020001848 Bedingham et al. Jan 2002 A1
20020009015 Laugharn, Jr. et al. Jan 2002 A1
20020015667 Chow Feb 2002 A1
20020021983 Comte et al. Feb 2002 A1
20020037499 Quake et al. Mar 2002 A1
20020039783 McMillan et al. Apr 2002 A1
20020053399 Soane et al. May 2002 A1
20020054835 Robotti et al. May 2002 A1
20020055167 Pourahmadi et al. May 2002 A1
20020060156 Mathies et al. May 2002 A1
20020068357 Mathies et al. Jun 2002 A1
20020141903 Parunak et al. Oct 2002 A1
20020142471 Handique et al. Oct 2002 A1
20020143297 Francavilla et al. Oct 2002 A1
20020143437 Handique et al. Oct 2002 A1
20020169518 Luoma et al. Nov 2002 A1
20020187557 Hobbs et al. Dec 2002 A1
20030019522 Parunak Jan 2003 A1
20030049833 Chen et al. Mar 2003 A1
20030070677 Handique et al. Apr 2003 A1
20030073106 Johansen et al. Apr 2003 A1
20030083686 Freeman et al. May 2003 A1
20030087300 Knapp et al. May 2003 A1
20030127327 Kurnik Jul 2003 A1
20030136679 Bohn et al. Jul 2003 A1
20030186295 Colin et al. Oct 2003 A1
20030199081 Wilding et al. Oct 2003 A1
20030211517 Carulli et al. Nov 2003 A1
20040014238 Krug et al. Jan 2004 A1
20040029258 Heaney et al. Feb 2004 A1
20040053290 Terbrueggen et al. Mar 2004 A1
20040063217 Webster et al. Apr 2004 A1
20040072278 Chou et al. Apr 2004 A1
20040072375 Gjerde et al. Apr 2004 A1
20040141887 Mainquist et al. Jul 2004 A1
20040151629 Pease et al. Aug 2004 A1
20040157220 Kurnool et al. Aug 2004 A1
20040161788 Chen et al. Aug 2004 A1
20040189311 Glezer et al. Sep 2004 A1
20040209331 Ririe Oct 2004 A1
20040209354 Mathies et al. Oct 2004 A1
20040219070 Handique Nov 2004 A1
20040240097 Evans Dec 2004 A1
20050009174 Nikiforov et al. Jan 2005 A1
20050048540 Inami et al. Mar 2005 A1
20050084424 Ganesan et al. Apr 2005 A1
20050106066 Saltsman et al. May 2005 A1
20050121324 Park et al. Jun 2005 A1
20050133370 Park et al. Jun 2005 A1
20050135655 Kopf-sill et al. Jun 2005 A1
20050152808 Ganesan Jul 2005 A1
20050170362 Wada et al. Aug 2005 A1
20050202470 Sundberg et al. Sep 2005 A1
20050202504 Anderson et al. Sep 2005 A1
20050208676 Kahatt Sep 2005 A1
20050220675 Reed et al. Oct 2005 A1
20050227269 Lloyd et al. Oct 2005 A1
20050233370 Ammann et al. Oct 2005 A1
20050238545 Parce et al. Oct 2005 A1
20050272079 Burns et al. Dec 2005 A1
20060041058 Yin et al. Feb 2006 A1
20060057039 Morse et al. Mar 2006 A1
20060057629 Kim Mar 2006 A1
20060062696 Chow et al. Mar 2006 A1
20060094108 Yoder et al. May 2006 A1
20060113190 Kurnik Jun 2006 A1
20060133965 Tajima et al. Jun 2006 A1
20060134790 Tanaka et al. Jun 2006 A1
20060148063 Fauzzi et al. Jul 2006 A1
20060165558 Witty et al. Jul 2006 A1
20060165559 Greenstein et al. Jul 2006 A1
20060166233 Wu et al. Jul 2006 A1
20060177376 Tomalia et al. Aug 2006 A1
20060183216 Handique Aug 2006 A1
20060207944 Siddiqi Sep 2006 A1
20060246493 Jensen et al. Nov 2006 A1
20060246533 Fathollahi et al. Nov 2006 A1
20070004028 Lair et al. Jan 2007 A1
20070009386 Padmanabhan et al. Jan 2007 A1
20070020699 Carpenter et al. Jan 2007 A1
20070026421 Sundberg et al. Feb 2007 A1
20070042441 Masters et al. Feb 2007 A1
20070092901 Ligler et al. Apr 2007 A1
20070098600 Kayyem et al. May 2007 A1
20070099200 Chow et al. May 2007 A1
20070104617 Coulling et al. May 2007 A1
20070154895 Spaid et al. Jul 2007 A1
20070177147 Parce Aug 2007 A1
20070178607 Prober et al. Aug 2007 A1
20070184463 Molho et al. Aug 2007 A1
20070184547 Handique et al. Aug 2007 A1
20070196238 Kennedy et al. Aug 2007 A1
20070199821 Chow Aug 2007 A1
20070215554 Kreuwel et al. Sep 2007 A1
20070218459 Miller et al. Sep 2007 A1
20070231213 Prabhu et al. Oct 2007 A1
20070261479 Spaid et al. Nov 2007 A1
20070269861 Williams et al. Nov 2007 A1
20070292941 Handique et al. Dec 2007 A1
20080000774 Park et al. Jan 2008 A1
20080050804 Handique et al. Feb 2008 A1
20080056948 Dale et al. Mar 2008 A1
20080075634 Herchenbach et al. Mar 2008 A1
20080090244 Knapp et al. Apr 2008 A1
20080095673 Xu Apr 2008 A1
20080118987 Eastwood et al. May 2008 A1
20080124723 Dale et al. May 2008 A1
20080149840 Handique et al. Jun 2008 A1
20080160601 Handique Jul 2008 A1
20080182301 Handique et al. Jul 2008 A1
20080192254 Kim et al. Aug 2008 A1
20080247914 Edens et al. Oct 2008 A1
20080262213 Wu et al. Oct 2008 A1
20090047713 Handique Feb 2009 A1
20090129978 Wilson et al. May 2009 A1
20090130719 Handique May 2009 A1
20090130745 Williams et al. May 2009 A1
20090131650 Brahmasandra et al. May 2009 A1
20090134069 Handique May 2009 A1
20090136385 Handique et al. May 2009 A1
20090136386 Duffy et al. May 2009 A1
20090155123 Williams et al. Jun 2009 A1
20090221059 Handique et al. Sep 2009 A1
20090223925 Morse et al. Sep 2009 A1
20100009351 Brahmasandra et al. Jan 2010 A1
Foreign Referenced Citations (39)
Number Date Country
2294819 Jan 1999 CA
19929734 Dec 1999 DE
0766256 Apr 1997 EP
2672301 Aug 1992 FR
2795426 Dec 2000 FR
58212921 Dec 1983 JP
H07-290706 Nov 1995 JP
2001-515216 Sep 2001 JP
A-2001-527220 Dec 2001 JP
A-2003-500674 Jan 2003 JP
2005-514718 May 2005 JP
A-2005-204661 Aug 2005 JP
WO 8806633 Sep 1988 WO
WO 9205443 Apr 1992 WO
WO 9800231 Jan 1998 WO
WO 9822625 May 1998 WO
WO 9853311 Nov 1998 WO
WO 9901688 Jan 1999 WO
WO 9909042 Feb 1999 WO
WO 9912016 Mar 1999 WO
WO 9933559 Jul 1999 WO
WO 0105510 Jan 2001 WO
WO 0114931 Mar 2001 WO
WO 0127614 Apr 2001 WO
WO 0128684 Apr 2001 WO
WO 0141931 Jun 2001 WO
WO 0154813 Aug 2001 WO
WO 0189681 Nov 2001 WO
WO 02078845 Oct 2002 WO
WO 03012325 Feb 2003 WO
WO 03012406 Feb 2003 WO
WO 03055605 Jul 2003 WO
WO 2004007081 Jan 2004 WO
WO 2004074848 Sep 2004 WO
WO 2005011867 Feb 2005 WO
WO 2005108620 Nov 2005 WO
WO 2006079082 Jul 2006 WO
WO 2008060604 May 2008 WO
WO 2009012185 Jan 2009 WO
Related Publications (1)
Number Date Country
20110027151 A1 Feb 2011 US
Provisional Applications (1)
Number Date Country
60959437 Jul 2007 US
Continuations (1)
Number Date Country
Parent 12178557 Jul 2008 US
Child 12904901 US
Continuation in Parts (3)
Number Date Country
Parent 12218416 Jul 2008 US
Child 12178557 US
Parent 12218498 Jul 2008 US
Child 12218416 US
Parent 12173023 Jul 2008 US
Child 12218498 US